an increased frequency of T cells expressing the co-inhibitory receptors KLRG1 and TIGIT was detected. Importantly, the latter signature resembles the CD8 + T-cell signature associated with a ...
总之,这些发现揭示了一个先前未知的免疫细胞新亚群的动态相互作用,即tigit+treg-tgf-β-cd226+cd8+t,该作用轴不仅调控免疫环境的稳态,还为t1d提供 ...
Like PD-L1, TIGIT is thought to act as a molecular brake that stops T cells from attacking tumours, and tiragolumab is currently leading the pack among drugs targeting the immune checkpoint.
Like PD-L1, TIGIT is thought to act as a molecular brake that stops T cells from attacking tumours, and tiragolumab is currently leading the pack among drugs targeting the immune checkpoint.